100 related articles for article (PubMed ID: 17043650)
1. GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN.
Huang W; Chang HY; Fei T; Wu H; Chen YG
Oncogene; 2007 Apr; 26(17):2471-82. PubMed ID: 17043650
[TBL] [Abstract][Full Text] [Related]
2. PTEN, a general negative regulator of cyclin D expression.
Diao L; Chen YG
Cell Res; 2007 Apr; 17(4):291-2. PubMed ID: 17426697
[No Abstract] [Full Text] [Related]
3. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
[TBL] [Abstract][Full Text] [Related]
4. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
5. Changes related to phosphatidylinositol 3-kinase/Akt signaling in leiomyomas: possible involvement of glycogen synthase kinase 3alpha and cyclin D2 in the pathophysiology.
Karra L; Shushan A; Ben-Meir A; Rojansky N; Klein BY; Shveiky D; Levitzki R; Ben-Bassat H
Fertil Steril; 2010 May; 93(8):2646-51. PubMed ID: 19464003
[TBL] [Abstract][Full Text] [Related]
6. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
7. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
9. The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation.
Chung JH; Ostrowski MC; Romigh T; Minaguchi T; Waite KA; Eng C
Hum Mol Genet; 2006 Sep; 15(17):2553-9. PubMed ID: 16849370
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells.
Kida A; Kakihana K; Kotani S; Kurosu T; Miura O
Oncogene; 2007 Oct; 26(46):6630-40. PubMed ID: 17486076
[TBL] [Abstract][Full Text] [Related]
11. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
Zhu X; Kwon CH; Schlosshauer PW; Ellenson LH; Baker SJ
Cancer Res; 2001 Jun; 61(11):4569-75. PubMed ID: 11389092
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
13. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
14. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
15. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.
Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC
Cancer Res; 2005 Jul; 65(13):5792-801. PubMed ID: 15994955
[TBL] [Abstract][Full Text] [Related]
16. PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.
Mulholland DJ; Dedhar S; Wu H; Nelson CC
Oncogene; 2006 Jan; 25(3):329-37. PubMed ID: 16421604
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
18. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
[TBL] [Abstract][Full Text] [Related]
19. Antifolate/folate-activated HGF/c-Met signalling pathways in mouse kidneys-the putative role of their downstream effectors in cross-talk with androgen receptor.
Dudkowska M; Bajer S; Jaworski T; Zielińska J; Manteuffel-Cymborowska M; Grzelakowska-Sztabert B
Arch Biochem Biophys; 2009 Mar; 483(1):111-9. PubMed ID: 19135973
[TBL] [Abstract][Full Text] [Related]
20. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
